119 related articles for article (PubMed ID: 38639334)
1. Effects of bone marrow mesenchymal stem cell-conditioned medium on the proliferation and migration of liposarcoma cells.
Chen H; Sha N; Liu N; Hu H
Folia Histochem Cytobiol; 2024; 62(1):50-60. PubMed ID: 38639334
[TBL] [Abstract][Full Text] [Related]
2. Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway.
Xie C; Xie DY; Lin BL; Zhang GL; Wang PP; Peng L; Gao ZL
Br J Cancer; 2013 Sep; 109(5):1198-205. PubMed ID: 23887606
[TBL] [Abstract][Full Text] [Related]
3. The culture of temporary tumor-like bone marrow mesenchymal stem cells (TT-BMSC) and the detection of cell biology property.
Chen Y; Cong L; Yin X; Dong B; Han Y; Tu G
Ann Transplant; 2011; 16(3):49-58. PubMed ID: 21959510
[TBL] [Abstract][Full Text] [Related]
4. Bone Marrow-Derived Mesenchymal Stem Cells Promoted Cutaneous Wound Healing by Regulating Keratinocyte Migration via β
Huo J; Sun S; Geng Z; Sheng W; Chen R; Ma K; Sun X; Fu X
Mol Pharm; 2018 Jul; 15(7):2513-2527. PubMed ID: 29757659
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow mesenchymal stem cells-derived conditioned medium protects cardiomyocytes from hypoxia/reoxygenation-induced injury through Notch2/mTOR/autophagy signaling.
Li X; Xie X; Yu Z; Chen Y; Qu G; Yu H; Luo B; Lei Y; Li Y
J Cell Physiol; 2019 Aug; 234(10):18906-18916. PubMed ID: 30953350
[TBL] [Abstract][Full Text] [Related]
7. Thymoquinone-treated mouse mesenchymal stem cells-derived conditioned medium inhibits human breast cancer cells in vitro.
Hajmomeni P; Sisakhtnezhad S; Bidmeshkipour A
Chem Biol Interact; 2023 Jan; 369():110283. PubMed ID: 36450322
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow mesenchymal stem cells conditioned medium protects VSC4.1 cells against 2,5-hexanedione-induced autophagy via NGF-PI3K/Akt/mTOR signaling pathway.
Zhang X; Kong Y; Sun Y; Qian Z; Gao C; Shi X; Li S; Piao Y; Piao F
Brain Res; 2018 Oct; 1696():1-9. PubMed ID: 29705604
[TBL] [Abstract][Full Text] [Related]
9. NGF mediates protection of mesenchymal stem cells-conditioned medium against 2,5-hexanedione-induced apoptosis of VSC4.1 cells via Akt/Bad pathway.
Bai Q; Zou M; Zhang J; Tian Y; Wu F; Gao B; Piao F
Mol Cell Biochem; 2020 Jun; 469(1-2):53-64. PubMed ID: 32279149
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 and matrix metalloproteinase-2 are involved in mesenchymal stromal cell homing and engraftment to tumors.
Song C; Li G
Cytotherapy; 2011 May; 13(5):549-61. PubMed ID: 21171825
[TBL] [Abstract][Full Text] [Related]
11. Conditioned medium from the bone marrow mesenchymal stem cells modulates immune response via signal transduction and activator of transcription 6 signaling pathway in an allergic rhinitis mouse model.
Zou W; Zou P; Zhang J; Cai X; Mao X; Liu G
Allergol Immunopathol (Madr); 2022; 50(4):105-114. PubMed ID: 35789409
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell-derived conditioned medium attenuate angiotensin II-induced aortic aneurysm growth by modulating macrophage polarization.
Zhou YZ; Cheng Z; Wu Y; Wu QY; Liao XB; Zhao Y; Li JM; Zhou XM; Fu XM
J Cell Mol Med; 2019 Dec; 23(12):8233-8245. PubMed ID: 31583844
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow mesenchymal stem cells facilitate diabetic wound healing through the restoration of epidermal cell autophagy via the HIF-1α/TGF-β1/SMAD pathway.
Shi Y; Wang S; Zhang W; Zhu Y; Fan Z; Huang Y; Li F; Yang R
Stem Cell Res Ther; 2022 Jul; 13(1):314. PubMed ID: 35841007
[TBL] [Abstract][Full Text] [Related]
14. Bone mesenchymal stem cell-conditioned medium induces the upregulation of Smad6, which inhibits the BMP-4/Smad1/5/8 signaling pathway.
Fang H; Song P; Shen C; Liu X; Li H
Neurol Res; 2016 Nov; 38(11):965-972. PubMed ID: 27636090
[TBL] [Abstract][Full Text] [Related]
15. Conditioned media derived from mesenchymal stem cells induces apoptosis and decreases cell viability and proliferation in squamous carcinoma cell lines.
Bagheri R; Bitazar R; Talebi S; Alaeddini M; Etemad-Moghadam S; Eini L
Gene; 2021 May; 782():145542. PubMed ID: 33675953
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein 4 inhibits proliferation of bone marrow mesenchymal stem cells and enhances growth of neurospheres derived from the stem cells.
Li H; Yu S; Hao F; Sun X; Zhao J; Xu Q; Duan D
Cell Biochem Funct; 2018 Aug; 36(6):331-341. PubMed ID: 30028031
[TBL] [Abstract][Full Text] [Related]
17. [(*)AG490 could suppress bone marrow mesenchymal stem cells migration, mineralization and bone defect healing via inhibiting Jak2-STAT3 pathway].
Yu X; Wan QL; Li Z; Li ZB
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 May; 53(5):293-300. PubMed ID: 29972985
[No Abstract] [Full Text] [Related]
18. Bone marrow-derived mesenchymal stem cells maintain the resting phenotype of microglia and inhibit microglial activation.
Yan K; Zhang R; Sun C; Chen L; Li P; Liu Y; Peng L; Sun H; Qin K; Chen F; Huang W; Chen Y; Lv B; Du M; Zou Y; Cai Y; Qin L; Tang Y; Jiang X
PLoS One; 2013; 8(12):e84116. PubMed ID: 24391898
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin pretreatment enhanced the protective effect of bone marrow-derived mesenchymal stem cell-conditioned medium on lipopolysaccharide-induced endothelial cell injury.
Ge S; He W; Zhang L; Lin S; Luo Y; Chen Q; Zeng M
Mol Cell Endocrinol; 2022 May; 548():111612. PubMed ID: 35248651
[TBL] [Abstract][Full Text] [Related]
20. microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head.
Huang S; Li Y; Wu P; Xiao Y; Duan N; Quan J; Du W
J Cell Mol Med; 2020 Oct; 24(19):11512-11523. PubMed ID: 32871042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
